Cancer
Researchers from Zhejiang University have made a significant discovery in gene therapy, detailing the potential of chimeric antigen receptor (CAR) natural killer (NK) cells in eliminating tumors and treating B-cell lymphoma. This innovative approach overcomes some limitations of CAR T cells, paving the way for a safer and more effective
Cancer
A well-balanced diet is crucial for overall well-being and plays a significant role in supporting the body's natural defenses against diseases, including cancer. While no single food can guarantee cancer prevention, incorporating nutrient-dense foods can contribute to overall well-being and reduce the risk. This guide highlights ten cancer-fighting
Cancer
As a mum of two young boys, Maxine Hughes thought she had it all together, but behind the scenes, she was secretly battling an aggressive form of cancer. Despite her diagnosis of triple negative cancer, she continued to work as a translator on Disney's "Welcome to Wrexham&
Cancer
A team of researchers led by cancer genetics experts at the University of Birmingham has discovered a new hereditary condition, DIAL syndrome, which affects patients' ability to repair DNA. This condition leaves them at a greater risk of developing blood cancer and impairs their ability to repair damage caused
Cancer
Cancer patients in low- and middle-income countries, such as India, place a significant burden on their caregivers, who often experience physical, emotional, social, and financial challenges. A recent study explored the caregiver burden and quality of life among parents of children with cancer in the Indian context, highlighting the importance
Cancer
Researchers from Shenyang Pharmaceutical University have developed a novel approach to cancer gene therapy using bacteria-driven liposomes that synergize chemotherapy, ferroptosis, and immunotherapy for robust antitumor therapy. This innovative strategy has shown promise in enhancing the immunogenicity of tumor cells, triggering immunogenic cell death, and activating systemic antitumor immune responses.
Cancer
Researchers from the University of Leipzig have made a groundbreaking discovery in the field of personalized medicine, developing a new method to assess individualized susceptibility to chemotherapy and immune checkpoint inhibitors in gastric cancer patients. By using pretherapeutic endoscopic tissue cultures (ePDTCs), the team has demonstrated the feasibility of this
Cancer
Research published in the journal Pharmacological Research - Modern Chinese Medicine has shed light on the potential therapeutic effects of Thuja occidentalis in gastric cancer cells. The study, conducted by researchers at Mother Teresa Women's University, employed genome-wide expression profiling and evaluated the impact of Thuja on the
Cancer
Researchers at Heidelberg University have made new discoveries about the impact of Metformin on HPV-positive cancer cells, shedding light on its potential therapeutic uses. The study found that Metformin's effects on cancer cells were complex and influenced by various factors, including the presence of chemotherapeutic agents. The findings
Cancer
Research conducted by scientists at Ewha Womans University in Seoul, South Korea, has explored the potential of sodium butyrate (NaB) in overcoming acquired resistance to 5-fluorouracil (5-FU), a first-line chemotherapy for gastric cancer (GC). The study aimed to investigate the molecular mechanisms of NaB in GC cell lines, including its
Cancer
Princess Kate continued her unexpected day of engagements on Wednesday, visiting the Parachute Regiment after opening up about her cancer journey at the Colchester Hospital. The Princess of Wales, who is also Colonel-in-Chief of the Parachute Regiment, made a surprise stop at their 2 PARA Cultural Day, where she met
Cancer
Research by a team of scientists at the National Cancer Institute (NCI) has uncovered new molecular mechanisms for regulating MHC class II (MHC-II) expression in antigen-presenting cells (APCs). The study reveals that the E3 ubiquitin ligase March-I controls the turnover of surface pMHC-II on APCs, while the protein CD83 suppresses
